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Obesity is a highly important nutritional disorder in all species, including companion 
animals. Overweight in humans and rodents induces immunological alterations, 
resulting in a decreased resistance towards infections and concomitant disorders. This 
trial investigated whether diet-induced chronic obesity alters immunological 
parameters in adult healthy dogs. 
Sixteen adult beagles with a body condition score (BCS) of 3/5 (using a 5-point score 
system) were randomly assigned to a control (CG) and weight gain (WGG) group. 
Weight gain was induced by an energy dense diet (1759 kJ/100 gram dry matter), 
which was administered at 1.3 x maintenance energy requirement during 47 weeks 
(Weight Gain Period:WGP), where-after obese body weight was maintained during 
26 weeks (Stable Period:SP). The CG were maintained with the same diet at stable 
ideal body weight during the entire trial (WGP + SP = 73 weeks). 
 
Body weight and BCS were followed up weekly, while immunological parameters 
and leptin were measured at week 0-4-9-16-24-31-40-47-59-73. Body composition 
was determined using the deuterium-technique at week 0-20-35-47-73. Data were 
analyzed using Repeated Measures for which significance was set at P<0.05.  
 
After the WGP, a significant higher body weight was reached in the WGG. During 
the SP, body weight was maintained. The CG remained at initial body weight during 
both WGP and SP. 
A significant increase in absolute fat mass was noted in the WGG. Leptin (ng/ml) 
increased in the WGG from 1.88±0.29 to 14.95±1.90 during the WGP but dropped 
back to 6.16±1.30 in the SP. This adipokine remained at baseline level in the CG 
during both WGP (from 2.34±1.05 to 2.04±0.19) and SP (1.1±0.12). 
 
Proliferation of peripheral blood mononuclear cells (PBMC), stimulated by ConA, 
PHA and PWM was not altered during the WGP in both groups but was significantly 
lower in the WGG during the SP. Certain subtypes of PBMC (CD3, CD4, CD5 and 
MHC) were increased in the WGG at week 24, where-after it slowly decreased to be 
significantly lower at week 47, compared to the CG. Tumor necrosis factor α (TNF-
α) was undetectable in CG and WGG.  
Chronic obesity was successfully reached in this trial. Leptin and absolute fat mass 
run parallel with weight gain. From this study, it can be stated that lymphocyte 
function and phenotyping are altered during chronic obesity in adult healthy dogs, 
which might influence their body defence against infections and diseases. 
